Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20571 |
cis-PDA
哌啶-2,3-二羧酸,cis PDA |
GluR; NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
cis-PDA (cis PDA) 是一种通用的离子型受体拮抗剂。 cis-PDA 通过阻断 NMDA、AMPA 和红藻氨酸介导的反应发挥作用。 | |||
T31792 |
Filaminast
UNII-CDD69JC61J,Way-pda-641,WAY-PDA 641,CDD69JC61J |
PDE | Metabolism |
Filaminast (UNII-CDD69JC61J) 是磷酸二酯酶4抑制剂(PDE4抑制剂)和罗利普兰的类似物,罗利普兰被用作抗哮喘药物。 | |||
T33808 |
12-Oxo phytodienoic acid
12-Oxo-Phytodienoic acid,12-OPDA,12-oxo PDA,OPDA |
Others | Others |
12-Oxo phytodienoic acid (12-oxo PDA) 是具有生物活性的 7-epi jasmonic acid 的直接前体。12-Oxo phytodienoic acid 在介导对病原体和害虫的抗性中起非依赖性作用。 | |||
T4367 |
Mycro 3
Mycro-3 |
c-Myc; Autophagy | Autophagy; Cell Cycle/Checkpoint |
Mycro 3 在全细胞分析中对 c-Myc 具有强效选择性,可用于胰腺癌的研究。 | |||
T73552 |
BPDA2
|
||
BPDA2为高选择性竞争性SHP2活性位点抑制剂,SHP2的IC50为92.0 nM, 对SHP1及SHP1B的IC50则分别为33.39 μM与40.71 μM。该化合物降低了有丝分裂促进因子、细胞存活信号以及RTK的表达,并抑制了SHP2介导的信号传导,影响乳腺癌细胞表型。 | |||
T10877 |
CPDA
|
Phosphatase | Metabolism |
CPDA 是新型 SH2 domain-containing inositol phosphatase 2 抑制剂,能够作用于3T3-L1脂肪细胞,改善胰岛素抗性。 | |||
T79622 |
h-NTPDase-IN-3
|
Phosphatase | Metabolism |
h-NTPDase-IN-3 是一种 h-NTPDase 抑制剂,抑制 h-NTPDase1,h-NTPDase2,h-NTPDase3 和 h-NTPDase8。 | |||
T18997 |
GPDA
Glycylproline p-nitroanilide tosylate,GPN |
Others | Others |
GPDA (Glycylproline p-nitroanilide tosylate) 是一种酶促反应检测底物,用于检测脯氨酰二肽氨基肽酶。 | |||
T79492 |
h-NTPDase8-IN-1
|
Phosphatase | Metabolism |
h-NTPDase8-IN-1 是一种特异性氨磺酰苯甲酰胺类 h-NTPDases8 抑制剂(IC 50 = 0.28 ± 0.07 μM)。h-NTPDase8-IN-1 可用于研究 h -NTPDase 表达异常带来的疾病。 | |||
T79607 |
h-NTPDase-IN-2
hNTPDase-IN-2 |
Phosphatase | Metabolism |
h-NTPDase-IN-2 是一种广谱 NTPDase 抑制剂,对多种 h-NTPDas 亚型都具有抑制作用。 | |||
T77661 |
h-NTPDase-IN-4
|
Phosphatase | Metabolism |
h-NTPDase-IN-4 是 NTPDase 的泛抑制剂,对 h-NTPDase1, 1h-NTPDase2, h-NTPDase3, h-NTPDase8具有抑制作用,IC50 分别为 3.58 μM , 10.21 μM , 0.13 μM , 13.57 μM 。 | |||
T24604 |
PDAT
Propyl Dimethyl Amino Tryptamine |
||
PDAT is a noncompetitive Indolethylamine N-methyltransferase inhibitor. | |||
T62703 |
NTPDase-IN-2
|
||
NTPDase-IN-2 (化合物 5g) 是一种具有选择性的NTPDase 抑制剂,其对h-NTPDase-2/-8的IC50值分别为 0.04 和 2.27 µM。NTPDase-IN-2 可非竞争性地抑制h-NTPDase-1/-2,其对h-NTPDase-2的Km 值为 74 µM。NTPDase-IN-2 可用于癌症、免疫学疾病以及细菌感染的研究。 | |||
T61377 |
NTPDase-IN-1
|
||
NTPDase-IN-1 (compound 5a) is a selective inhibitor of NTPDase enzymes. It shows inhibitory activity against h-NTPDase-1, h-NTPDase-2, and h-NTPDase-8 with IC50 values of 0.05 μM, 0.23 μM, and 0.54 μM, respectively. NTPDase-IN-1 exerts non-competitive inhibition on h-NTPDase-1 and h-NTPDase-2, with a K m value of 21 μM for h-NTPDase-1. This compound is useful for investigating various conditions like cancer, immunologic disorders, and bacterial infections [1]. | |||
TQ0114 |
CMPDA
|
GluR | Neuroscience |
CMPDA is a positive allosteric modulator of AMPA receptors (EC50s: 45.4 nM/63.4 nM for GluA2i/GluA2o receptor). | |||
T79623 |
h-NTPDase-IN-5
|
Phosphatase | Metabolism |
h-NTPDase-IN-5(化合物3b)是一种NTPDase的泛抑制剂,其IC50s对于h-NTPDase1为1.10 μM,h-NTPDase2为44.73 μM,h-NTPDase3为26.14 μM,h-NTPDase8为0.32 μM。 | |||
T79491 |
h-NTPDase-IN-1
|
Phosphatase | Metabolism |
h-NTPDase-IN-1 (Compound 3i) 是一种针对 h-NTPDase 的抑制剂,对 h-NTPDase1 和 h-NTPDase3 的抑制作用表现在 IC50 值分别为 2.88 μM 和 0.72 μM。该化合物在血栓、炎症、糖尿病及癌症研究领域有潜在应用。 | |||
T23179 |
PPDA
|
Others | Others |
Subtype-selective NMDA receptor antagonist | |||
T62633 |
NTPDase-IN-3
|
||
NTPDase-IN-3 (Compound 5e) 是一种 NTPDase 抑制剂,IC50值分别为 0.38 μM (NTPDase3), 0.05 μM (NTPDase8), 0.21 μM (NTPDase1), 1.07 μM (NTPDase2)。NTPDase-IN-3 可用于癌症和血栓形成的研究。 | |||
T37396 |
13-epi-12-oxo Phytodienoic Acid
|
||
13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn. ω-3 and ω-6 polyunsaturated fatty acids in plants are substrates for plant lipoxygenases. 12-oxo PDA is one of the best studied end metabolites of this enzymatic pathway. While the initial enzymatic product and major isomer of 12-oxo PDA contains side chains in the cis position, both being β to the ring, the upper side chain attached at C-13, can and fr... | |||
TQ0095 |
Brincidofovir
CMX001,HDP-CDV |
Others; Antiviral; HSV | Immunology/Inflammation; Microbiology/Virology; Others |
Brincidofovir (HDP-CDV) 是 Cidofovir 的一种具有口服活性的亲脂性形式的前体药物,是一种口服长效的抗病毒药物,有广泛的抗 DNA 病毒活性。 | |||
T68713 |
RX-RA 69
|
||
RX-RA 69 is a pyrimido-pyrimidine derivative and PDA-inhibitor which inhibits tumor cell induced platelet aggregation in vitro. |